Anthony L. Vaccarino, PhD

  • 3Articles
  • 11.8KReads
  • 2009–2024Active
  • 39Collaborators
  • 82Citations

About

Anthony L. Vaccarino, PhD, is affiliated with Indoc Research in Toronto, Canada. Since 2009, Vaccarino has contributed to research on topics including anxiety, anxiolytics, cognition, COVID, depression (MDD), and electroconvulsive therapy. The author has frequently collaborated with Amir H. Kalali, Arun V. Ravindran, Benicio N. Frey, the CAN-BIND Investigator Team, and Claudio N. Soares.

Publications

JCP
Cognitive Effects of ECT in Schizophrenia: A Review
Review Article

Cognitive Effects of ECT in Schizophrenia: A Review

June 5, 2024

ECT was not associated with any significant cognitive deficits in people with treatment-resistant schizophrenia across global cognition, attention, language, visuospatial function, and executive function domains. The majority of studies...
,
JCP
Original Research

CAN-BIND-1 Outcomes and Early Response Prediction in MDD

February 5, 2019

Antidepressant medications are often prescribed with little certainty about their potential effectiveness in individual patients. Can early symptom reduction help predict later symptomatic and functional outcomes of antidepressant treatment?...
, , , et al
JCP
Original Research

Assessing Onset of Treatment Benefit in Depression and Anxiety: Conceptual Considerations

August 15, 2009

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe